Siemens and GE gain in echo competition
The pecking order in the U.S. echocardiography market remains unchanged, but Siemens and GE are gaining ground, according to a report by Klein Biomedical. Market leader Philips Medical Systems lost share last year to both Siemens and GE Medical. Siemens
The pecking order in the U.S. echocardiography market remains unchanged, but Siemens and GE are gaining ground, according to a report by Klein Biomedical. Market leader Philips Medical Systems lost share last year to both Siemens and GE Medical. Siemens is closing in from its number two position; GE is ranked third. Siemens' gains are coming from the growing popularity of its Acuson Sequoia. Unit shipments of the company's flagship product increased more than 21%, according to Siemens, making Sequoia the best-selling ultrasound system in the U.S. for the sixth year in a row. The Klein report estimates that the U.S. market for ultrasound was essentially flat in 2002, with total revenues of $1.14 billion, managing a mere 0.3% percent increase over 2001.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
